Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer's Connecticut Sequencing Lab Receives CLIA Certification

NEW YORK (GenomeWeb News) – PerkinElmer said today that it has received Clinical Laboratory Improvement Amendments certification and a license from the State of Connecticut for its DNA Sequencing Services Laboratory in Branford.

PerkinElmer said that certification will enable it to expand its offerings to include clinical sequencing services for analysis of specific diseases including cancer and Mendelian diseases, as well as diagnostics services for new drugs and for pharmaceutical clinical trial studies.

"The tests performed at the next generation sequencing laboratory include DNA exome and targeted sequencing as well as RNA sequencing," Richard Begley, president of emerging technologies at PerkinElmer, said in a statement. "PerkinElmer's objective is to offer the broadest array of genomic and proteomic diagnostics as well as tools for more efficient research and drug discovery."

PerkinElmer's services portfolio includes DNA/RNA extraction; high-throughput plate reader assessment of DNA quantity and quality; statistical visualization and annotation tools for microarray and next-gen sequencing data; library preparation with liquid handling; as well as sequencing and analysis services.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.